Categories: News

EU allows Malaysians jabbed with WHO-approved COVID-19 vaccines to enter

The European Union (EU) has clarified today that anybody who has received COVID-19 vaccines authorised by its member countries are allowed to enter, following reports that the EU Digital COVID Certificate only approves jabs approved by the bloc.

It added that its member states have also lifted travel restrictions for those who received COVID-19 vaccines that are yet to be approved by the EU, as long as the manufacturers have gone through the World Health Organisation’s (WHO) Emergency Use Listing process.

COVID-19: travel from third countries into the EU. Source: EU

“Entry into the EU is in principle allowed to fully vaccinated persons with one of the vaccines authorised in the EU, including those produced in facilities not covered by marketing authorisation in the EU,” it said in a statement.

“Member States could also allow entry for people vaccinated with vaccines that have not been yet authorised in the EU but have completed the WHO Emergency Use Listing process.

“There is no obstacle or hurdle. Therefore, some recent reporting concerning the AstraZeneca vaccines’ origin is inaccurate,” it added.

The union said that the digital proof of one’s status on COVID-19 dubbed “EU Digital COVID Certificate” is not a prerequisite for travelling in the EU nor a compulsory document, but simply a practical tool.

It added that EU Digital COVID Certificate is not the only tool to be used to travel to the countries under the union as Member States are free to accept other vaccine documentations.

“These should contain information that at least allows identifying the person, the type of vaccine and the date of the administration of the vaccine. Official certificates certifying recovery from COVID-19 or a negative COVID-19 test may also serve as a proof of low epidemiological risk, depending on the legislation in force of the Member State Malaysians wish to visit.

“In addition, it is up to EU Member States to decide which obligations, such as quarantine, may be imposed on incoming travellers,” it added.

The union advised Malaysians who wish to travel to its Member States to check the entry requirements for the countries they wish to visit.

On Monday, Science, Technology and Innovation Minister Khairy Jamaluddin said there is no reason for the EU to “discriminate” between the different AstraZeneca manufacturing locations as all of them adhere to the good manufacturing practice.

AstraZeneca vaccines produced by Siam Bioscience. Source: KKM

This comes as healthcare news portal CodeBlue reported that Malaysians vaccinated with the AstraZeneca vaccine may be barred from entering Europe, as the EU Digital COVID Certificate does not cover AstraZeneca doses made by South Korea’s SK Bioscience or Thailand’s Siam Bioscience — which is used here. — Malay Mail

[ IMAGE SOURCE ]

Recent Posts

MITI increases minimum CBU EV price to RM300K? Imported EVs with 240hp and below not allowed?

Ministry of Investment, Trade and Industry's (MITI) electric vehicle (EV) policy debacle continues with yet…

49 minutes ago

The Best Camera is the One You Have with You; The OPPO Find X9 Ultra Wants to be Your Only One

This post is brought to you by OPPO. We’ve all heard the old photography adage:…

4 hours ago

Infinix GT 50 Pro launched in Malaysia: Gaming phone with Dimensity 8400 Ultimate, 144Hz AMOLED, 6500mAh battery, priced from RM1,899

Infinix has launched its latest gaming smartphone in Malaysia, the Infinix GT 50 Pro. Replacing…

17 hours ago

Merdeka 118 has 32 EV charging bays deployed by ChargEV

Ahead of Merdeka 118 Mall opening sometime in August, ChargEV has deployed a large scale…

1 day ago

DNB activates indoor 5G coverage at Pavilion KL, expands In-Building Solution across Malaysia

Shoppers and visitors at Pavilion Kuala Lumpur can now get better 5G coverage indoors, following…

1 day ago

TNB Electron turns on 120kW DC Charger at Hotel Casuarina Meru in Perak

TNB Electron has turned on a new DC charger in Ipoh and it is their…

1 day ago

This website uses cookies.